Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Medicines beyond barriers

Videos
medicines beyond barriersG2B

At Gate2Brain, we have found the key to unlocking the gate to the brain . We have developed a unique shuttle technology to cross the blood-brain barrier. A technology based on a set of peptides to allow the different therapeutic agents to reach the brain in a non-invasive form.

Our first target is pediatric high grades gliomas which is a group of non-curable and fast acting CNS disorders. Gate2Brain’s technology can be applied to other molecules and to other brain diseases. Gate2Brain holds the potential to treat some of the most devastating human diseases.

We are working to bring this technology to the market and go beyond barriers.

 

 

June 29, 2022/by noticias
Tags: Biotech, Innovation, medicinesbeyondbarriers, pediatriccancer, research
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/06/Copia-de-EmpresaCultura-CREO.png 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-06-29 10:17:172022-06-29 10:35:02Medicines beyond barriers
You might also like
2 year anniversaryGate2BrainGate2Brain 2 year highlights at a glance
EITHealth Catapult 2022eithealthGate2Brain semifinalist of EITHealth’s Catapult 2022
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & Innovation
It’s Gate2Brain second anniversary!! 🎂 The creativity, work and dedication of Gate2Brain's team can only be matched with its desire to bring medicines beyond barriers.Gate2BrainGate2Brain second anniversary
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansiónTHIS IS HOW A DRUG IS TOWED TO THE BRAIN
talento científicotalento cientificoFounding a company in times of pandemic
Sustainability Policies, Innovation, Entrepreneurship and New Production Models.g2bSustainability Policies, Innovation, Entrepreneurship and New Production Models

CATEGORIES

  • Clipping
  • Events
  • Media
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • BioSpain 2023G2BBioSpain 2023September 29, 2023 - 17:51
  • summer retreatGate2Brain’s Summer Retreat 2023July 24, 2023 - 09:42
  • Bits & PretzelsG2BBits & PretzelsJune 22, 2023 - 12:15
  • 17th China International Peptide Academic Symposium17th China International Peptide Academic SymposiumJune 19, 2023 - 09:15
  • Frontiers of Innovation and EntrepreneurshipG2BFrontiers of Innovation and EntrepreneurshipJune 13, 2023 - 10:40

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • BCN Health Booster companies complete first year of the program with flying colors September 27, 2023 biocat
  • September picks: Barcelona, benchmark site for international events in the sector September 27, 2023 biocat
  • Presentation of road map to accelerate the adoption of innovation to the Catalan Health System September 27, 2023 biocat
  • 6th edition of CRAASH Barcelona kicks off September 8, 2023 biocat
  • Join us for the second Barcelona Health Innovation Week 2024 September 6, 2023 biocat
  • HIGHLIGHTS: News in CAR-T, Orikine round, Roche investment in Catalonia, first genetic variant for multiple sclerosis July 27, 2023 biocat
  • From medical history to research: European framework for secondary use of health data July 26, 2023 biocat
  • Debate on: Future European Health Data Space July 26, 2023 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Gate2Brain semifinalist of EITHealth’s Catapult 2022EITHealth Catapult 2022eithealthGate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}